Compare OPXS & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | CSBR |
|---|---|---|
| Founded | 1987 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.7M | 98.5M |
| IPO Year | N/A | 1986 |
| Metric | OPXS | CSBR |
|---|---|---|
| Price | $15.48 | $7.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 68.2K | 5.1K |
| Earning Date | 12-16-2025 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.55 | N/A |
| EPS | ★ 0.74 | 0.17 |
| Revenue | $41,337,000.00 | ★ $58,424,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | ★ $20.18 | $41.89 |
| Revenue Growth | ★ 21.60 | 9.06 |
| 52 Week Low | $5.36 | $5.59 |
| 52 Week High | $17.76 | $11.98 |
| Indicator | OPXS | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 50.45 | 56.94 |
| Support Level | $14.64 | $6.62 |
| Resistance Level | $16.02 | $7.71 |
| Average True Range (ATR) | 0.88 | 0.33 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 36.19 | 69.72 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.